| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 27.170 | 47.941 | 25.784 | 48.264 | 61.793 | 60.453 | 60.610 | 0 | 157.269 |
| Total Income - EUR | - | 27.170 | 47.941 | 25.784 | 48.264 | 61.793 | 60.453 | 60.620 | 69 | 157.269 |
| Total Expenses - EUR | - | 5.804 | 13.588 | 4.309 | 2.637 | 9.205 | 7.420 | 7.615 | 652 | 152.299 |
| Gross Profit/Loss - EUR | - | 21.366 | 34.353 | 21.476 | 45.627 | 52.589 | 53.033 | 53.006 | -582 | 4.971 |
| Net Profit/Loss - EUR | - | 21.094 | 33.874 | 21.093 | 44.593 | 52.018 | 52.428 | 52.412 | -582 | 4.175 |
| Employees | - | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 2 |
Check the financial reports for the company - Pharm A-Z Business S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 94 | 55 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 22.425 | 34.554 | 54.399 | 46.043 | 53.012 | 53.401 | 54.122 | 137 | 99.710 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 466 | 679 | 25.953 | 40.428 | 40.386 | 44.161 | 0 | 95.161 |
| Cash | - | 22.425 | 34.087 | 53.720 | 20.090 | 12.584 | 13.015 | 9.960 | 137 | 4.549 |
| Shareholders Funds | - | 21.139 | 33.925 | 54.395 | 44.851 | 52.266 | 52.671 | 52.655 | -340 | 3.838 |
| Social Capital | - | 45 | 44 | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 1.380 | 684 | 21 | 1.192 | 745 | 730 | 1.467 | 477 | 95.872 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharm A-Z Business S.r.l.